ClinicalTrials.Veeva

Menu

Clinical Efficiency of Bioactive Pit and Fissure Sealant

Cairo University (CU) logo

Cairo University (CU)

Status and phase

Not yet enrolling
Phase 2

Conditions

Pit and Fissure Sealant

Treatments

Other: BioCoat® by Premier®
Other: UltraSeal XT™ plus by Ultradent

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This study will compare the performance of newly introduced bioactive resin based pits and fissure sealant versus fluoride releasing filled resin based pits and fissure sealant in posterior molars prone to carious lesions of fissures in patients at risk of caries. Visual tactile examination and VistaCAM will be used for evaluation.

Full description

New bioactive resin pits and fissures sealant BioCoat® by Premier® presenting SmartCap™ Technology involving semi-permeable resin microcapsules. The rechargeable SmartCap microcapsules are filled with ionic solutions of fluoride, calcium and phosphate, supposing greater fluoride uptake in the presence of calcium and phosphate ions.

With no enough evidence based information in literature about using bioactive fissure sealants in susceptible fissures , it isd beneficial to evaluate the newly introduced material using a randomized clinical trial to test the null hypothesis that bioactive resin pit and fissure sealant will have the same clinical performance as flouride releasing filled resin based pit and fissure sealant in susceptible fissures.

Enrollment

40 estimated patients

Sex

All

Ages

6 to 10 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Inclusion Criteria of participants:

    • Patients with caries susceptible fiss- ures in fully erupted first permanent molars showing nosigns of caries.
    • Co-operative patients approving to part- icipate in the trial.
    • Good oral hygiene.
  • Inclusion Criteria of teeth:

    • Caries susceptible occlusal pits and fissures.
    • Intact contact with opposing teeth.
    • Teeth with no previous restorations in other surfaces.

Exclusion criteria

  • Exclusion criteria of participants:

    • patients with Disabilities, systemic disease or severe medical complications.
    • patients have allergic history concerning methacrylate.
    • patients with rampant caries, xerostomia, evidence of severe bruxism, clenching, or tempromandibular joint disorders
    • participants who show lack of compliance.
  • Exclusion criteria of teeth:

    • Carious pits and fissures.
    • Developmental tooth defect.
    • Partially erupted teeth
    • Periapical pathology or signs of pulpal pathology.
    • Tooth hypersensitivity.
    • Heavy occlusion and occlusal contacts.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

40 participants in 2 patient groups

Control group (A)
Active Comparator group
Description:
Fluoride releasing filled resin based pit and fissure sealant using UltraSeal XT™ plus by Ultradent
Treatment:
Other: UltraSeal XT™ plus by Ultradent
Interventional group (B)
Experimental group
Description:
Bioactive pit and fissure sealant using BioCoat® by Premier®
Treatment:
Other: BioCoat® by Premier®

Trial contacts and locations

0

Loading...

Central trial contact

Samaa Salah, Msc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems